BBIO
BridgeBio Pharma Inc
66.30$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -341.7% | – | – | – | – | – | – | – | – | |
| – | -3.3% | +0.7% | -1.4% | -2.3% | -11.1% | -6.1% | +2.6% | +6.2% | +3.9% | +25.3% | +5.9% | – | |
| – | +63.8% | -53.9% | +25.8% | +26.6% | +10.9% | -14.1% | +43.9% | -5.3% | -1.8% | -4.0% | +32.6% | – | |
| – | +1,576.5% | -1,124.6% | – | -100.9% | – | -997.4% | – | -120.2% | – | -351.4% | – | – | |
| – | +0.9% | +243.0% | +64.0% | -29.2% | +86.9% | -50.7% | +219.4% | -90.8% | +864.5% | -98.5% | +542.0% | – | |
| – | -100.2% | – | -86.6% | +1,157.8% | -108.5% | -50.7% | +715.2% | – | -408.1% | +210.7% | – | – | |
| – | -2.1% | +14.9% | -40.6% | -17.2% | -2.7% | +3,465.0% | -96.0% | – | -247.1% | +1,387.3% | +54.5% | – | |
| – | – | – | – | – | – | -76.8% | +158.6% | -200.0% | -100.0% | – | -100.0% | – | |
| – | -101.5% | – | -102.0% | – | +66,934.1% | -87.3% | +400.7% | -100.3% | +211.2% | – | -154.3% | – | |
| – | -164.9% | – | -13.0% | -296.7% | – | -151.0% | – | -151.0% | – | – | -262.7% | – | |
| – | – | – | – | -352.3% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.